Compare stocks

Tecan Group AG is a Switzerland-based company operating in the life sciences industry, primarily providing laboratory instruments and solutions for automated workflows. Founded in 1980 and headquartered in Männedorf, Switzerland, the company designs and manufactures a range of products including liquid handling and robotic workflow solutions, microplate readers, and various laboratory software applications. Tecan's products serve laboratories in biopharmaceuticals, forensics, and diagnostics sectors, enhancing productivity and precision in research processes. Leveraging its technological expertise, Tecan emphasizes modular and scalable solutions that cater to diverse laboratory needs globally. Its strategic positioning revolves around innovation in automation technology to improve laboratory efficiency.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.